Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Comparative assessment of insecticide resistance phenotypes in two major malaria vectors, Anopheles funestus and Anopheles arabiensis in south-eastern Tanzania
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4652563
Author(s) Pinda, P. G.; Eichenberger, C.; Ngowo, H. S.; Msaky, D. S.; Abbasi, S.; Kihonda, J.; Bwanaly, H.; Okumu, F. O.
Author(s) at UniBasel Eichenberger, Claudia
Year 2020
Title Comparative assessment of insecticide resistance phenotypes in two major malaria vectors, Anopheles funestus and Anopheles arabiensis in south-eastern Tanzania
Journal Malar J
Volume 19
Number 1
Pages / Article-Number 408
Keywords Anopheles funestus; Ifakara health institute; Insecticide resistance; Pbo; Tanzania
Mesh terms Animals; Anopheles, genetics; Insecticide Resistance, genetics; Insecticide-Treated Bednets; Insecticides, pharmacology; Mosquito Control; Mosquito Vectors, genetics; Nitriles, pharmacology; Organothiophosphorus Compounds, pharmacology; Permethrin, pharmacology; Phenotype; Phenylcarbamates, pharmacology; Piperonyl Butoxide, pharmacology; Pyrethrins, pharmacology; Species Specificity; Tanzania
Abstract BACKGROUND: Long-lasting insecticide-treated nets (LLINs) and indoor residual spraying (IRS) have greatly reduced malaria transmission in sub-Saharan Africa, but are threatened by insecticide resistance. In south-eastern Tanzania, pyrethroid-resistant Anopheles funestus are now implicated in > 80% of malaria infections, even in villages where the species occurs at lower densities than the other vector, Anopheles arabiensis. This study compared the insecticide resistance phenotypes between the two malaria vectors in an area where pyrethroid-LLINs are widely used. METHODS: The study used the World Health Organization (WHO) assays with 1x, 5x and 10x insecticide doses to assess levels of resistance, followed by synergist bioassays to understand possible mechanisms of the observed resistance phenotypes. The tests involved adult mosquitoes collected from three villages across two districts in south-eastern Tanzania and included four insecticide classes. FINDINGS: At baseline doses (1x), both species were resistant to the two candidate pyrethroids (permethrin and deltamethrin), but susceptible to the organophosphate (pirimiphos-methyl). Anopheles funestus, but not An. arabiensis was also resistant to the carbamate (bendiocarb). Both species were resistant to DDT in all villages except in one village where An. arabiensis was susceptible. Anopheles funestus showed strong resistance to pyrethroids, surviving the 5x and 10x doses, while An. arabiensis reverted to susceptibility at the 5x dose. Pre-exposure to the synergist, piperonyl butoxide (PBO), enhanced the potency of the pyrethroids against both species and resulted in full susceptibility of An. arabiensis (> 98% mortality). However, for An. funestus from two villages, permethrin-associated mortalities after pre-exposure to PBO only exceeded 90% but not 98%. CONCLUSIONS: In south-eastern Tanzania, where An. funestus dominates malaria transmission, the species also has much stronger resistance to pyrethroids than its counterpart, An. arabiensis, and can survive more classes of insecticides. The pyrethroid resistance in both species appears to be mostly metabolic and may be partially addressed using synergists, e.g. PBO. These findings may explain the continued persistence and dominance of An. funestus despite widespread use of pyrethroid-treated LLINs, and inform new intervention choices for such settings. In short and medium-term, these may include PBO-based LLINs or improved IRS with compounds to which the vectors are still susceptible.
ISSN/ISBN 1475-2875 (Electronic)1475-2875 (Linking)
URL https://doi.org/10.1186/s12936-020-03483-3
edoc-URL https://edoc.unibas.ch/91212/
Full Text on edoc Available
Digital Object Identifier DOI 10.1186/s12936-020-03483-3
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/33176805
ISI-Number WOS:000593841700005
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.406 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
03/05/2024